A new duplication in the mitochondrially encoded tRNA proline gene in a patient with dilated cardiomyopathy
Carregando...
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
INFORMA HEALTHCARE
Citação
MITOCHONDRIAL DNA, v.24, n.1, p.46-49, 2013
Resumo
Mitochondria provide an environment conducive to mutations in DNA molecules (mtDNA). Analyses of mtDNA have shown mutations potentially leading to many cardiovascular traits. Here, we describe a patient with dilated cardiomyopathy and new mtDNA duplication. The patient presented symptoms of heart failure New York Heart Association functional class III and was diagnosed with non-familial dilated cardiomyopathy with important left ventricular systolic dysfunction. Sequencing of mtDNA control region was done, and a 15 bp duplication was observed between nucleotides 16,018 and 16,032. Part of this duplication is localized within the tRNA proline gene (tRNA(Pro)) that has an important role in cell protection against oxidative stress and is considered an important regulatory factor for cellular reactive oxygen species balance. This duplication could alter the stability or secondary structure of tRNA(Pro), affecting mt-protein synthesis. In turn, the presence of duplication in tRNA(Pro) could cause some oxidative stress imbalance and, so, mitochondrial dysfunction could result in the pathogenicity.
Palavras-chave
Dilated cardiomyopathy, genetic duplication, mitochondrial DNA
Referências
- Albanesi Filho Francisco Manes, 2005, Arq Bras Cardiol, V85, P155, DOI 10.1590/S0066-782X2005001600001
- Andrews RM, 1999, NAT GENET, V23, P147
- Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014
- Blakely EL, 2009, ARCH NEUROL-CHICAGO, V66, P399, DOI 10.1001/archneurol.2008.576
- Blum A, 2009, ISR MED ASSOC J, V11, P105
- Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607
- BROCKINGTON M, 1993, NAT GENET, V4, P67, DOI 10.1038/ng0593-67
- Brule H, 1998, NUCLEIC ACIDS RES, V26, P537, DOI 10.1093/nar/26.2.537
- Budowle B, 2003, ANNU REV GENOM HUM G, V4, P119, DOI 10.1146/annurev.genoin.4.070802.110352
- Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008
- Da Pozzo P, 2009, EUR J HUM GENET, V17, P1092, DOI 10.1038/ejhg.2009.12
- Elango S, 2011, MITOCHONDRION, V11, P878, DOI 10.1016/j.mito.2011.07.002
- Grasbon-Frodl EM, 1999, NEUROGENETICS, V2, P121, DOI 10.1007/s100480050063
- Hung WY, 2008, MUTAGENESIS, V23, P137, DOI 10.1093/mutage/gen002
- IONASESCU VV, 1994, NEUROLOGY, V44, P975
- Kofler B, 2009, BMC MED GENET, V10, P1
- Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054
- Lee HR, 2006, J BIOL CHEM, V281, P36236, DOI 10.1074/jbc.M607964200
- Lindenfeld J, 2010, J CARD FAIL, V16, P475, DOI 10.1016/j.cardfail.2010.04.005
- MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284
- Seneca S, 2000, J INHERIT METAB DIS, V23, P853, DOI 10.1023/A:1026729223050
- TAKAGI K, 2004, HUM GENET ATHEROSCLE, V175, P281, DOI 10.1016/J.ATHEROSCLEROSIS.2004.03.008
- Tengan CH, 2002, BBA-MOL BASIS DIS, V1588, P65, DOI 10.1016/S0925-4439(02)00140-0
- TORRONI A, 1994, AM J HUM GENET, V55, P760
- Tsutsui H, 2006, INTERNAL MED, V45, P809, DOI 10.2169/internalmedicine.45.1765
- Wei YL, 2009, CLIN EXP PHARMACOL P, V36, P933, DOI 10.1111/j.1440-1681.2009.05183.x
- Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006
- Wong LJC, 2002, AM J MED GENET, V113, P59, DOI 10.1002/ajmg.10767
- Zhu HY, 2009, EUR J HUM GENET, V17, P1501, DOI 10.1038/ejhg.2009.63